Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGM - Nasdaq Real Time Price USD

Affimed N.V. (AFMD)

Compare
0.5701
-0.0619
(-9.79%)
At close: April 4 at 4:00:00 PM EDT
0.5800
+0.01
+(1.74%)
After hours: April 4 at 7:18:45 PM EDT
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
877
8,275
41,353
40,366
28,360
Operating Expense
74,681
119,413
130,326
105,362
63,356
Operating Income
-73,804
-111,138
-88,973
-64,996
-34,996
Net Non Operating Interest Income Expense
-74
238
-1,269
-1,127
46
Other Income Expense
3,912
4,965
4,240
8,602
-6,415
Pretax Income
-69,966
-105,935
-86,002
-57,521
-41,365
Tax Provision
4
3
2
2
1
Net Income Common Stockholders
-69,970
-105,938
-86,004
-57,523
-41,366
Diluted NI Available to Com Stockholders
-69,970
-105,938
-86,004
-57,523
-41,366
Basic EPS
-4.55
-7.09
-6.00
-4.80
-5.00
Diluted EPS
-4.55
-7.09
-6.00
-4.80
-5.00
Basic Average Shares
15,404.6860
14,939.9160
14,236.2290
11,950.2380
8,347.1550
Diluted Average Shares
15,404.6860
14,939.9160
14,236.2290
11,950.2380
8,347.1550
Total Operating Income as Reported
-70,206
-106,661
-88,119
-64,030
-34,718
Total Expenses
74,681
119,413
130,326
105,362
63,356
Net Income from Continuing & Discontinued Operation
-69,970
-105,938
-86,004
-57,523
-41,366
Normalized Income
-70,962.2400
-107,067.7000
-88,600.7300
-63,188.5300
-36,574.2800
Interest Income
1,272
509
--
--
186
Interest Expense
1,357
1,806
1,630
712
95
Net Interest Income
-74
238
-1,269
-1,127
46
EBIT
-68,609
-104,129
-84,372
-56,809
-41,270
EBITDA
-65,188
-102,380
-81,473
-55,475
-40,155
Reconciled Depreciation
3,421
1,749
2,899
1,334
1,115
Net Income from Continuing Operation Net Minority Interest
-69,970
-105,938
-86,004
-57,523
-41,366
Total Unusual Items Excluding Goodwill
1,256
1,430
3,287
7,761
-6,564
Total Unusual Items
1,256
1,430
3,287
7,761
-6,564
Normalized EBITDA
-66,444
-103,810
-84,760
-63,236
-33,591
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
263.7600
300.3000
690.2700
2,095.4700
-1,772.2800
12/31/2020 - 9/12/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ADAP Adaptimmune Therapeutics plc
0.2581
-20.31%
 
ARTV Artiva Biotherapeutics, Inc.
2.4400
-3.94%
 
FATE Fate Therapeutics, Inc.
0.7529
+10.72%
 
PRQR ProQR Therapeutics N.V.
1.1800
-7.09%
 
MREO Mereo BioPharma Group plc
1.9900
-9.95%
 
KYTX Kyverna Therapeutics, Inc.
1.9800
+0.51%
 
KPTI Karyopharm Therapeutics Inc.
3.8600
0.00%
 
CRIS Curis, Inc.
1.2300
-7.52%
 
ARWR Arrowhead Pharmaceuticals, Inc.
10.68
-11.44%
 
KOD Kodiak Sciences Inc.
2.3500
-2.08%